U.S. in Pact with Pfizer (PFE) for 100 Million Covid-19 Vaccine Doses - Bloomberg
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.66 +0.07%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Join SI Premium – FREE
U.S. in Pact with Pfizer (NYSE: PFE) for 100 Million Covid-19 Vaccine Doses - Bloomberg
Related: BioNTech SE (NASDAQ: BNTX)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lakewood-Amedex gets IRB approval for diabetic foot ulcer trial
- Novo Nordisk and Anthropic announce R&D collaboration
- EMA panel backs Novartis Cosentyx for rheumatic condition in EU
Create E-mail Alert Related Categories
Corporate News, FDA, Hot FDA NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
